Citation | Zhao, Y; Bai, L; Liu, L; McEachern, D; Stuckey, JA; Meagher, JL; Yang, CY; Ran, X; Zhou, B; Hu, Y; Li, X; Wen, B; Zhao, T; Li, S; Sun, D; Wang, S Structure-Based Discovery of 4-(6-Methoxy-2-methyl-4-(quinolin-4-yl)-9H-pyrimido[4,5-b]indol-7-yl)-3,5-dimethylisoxazole (CD161) as a Potent and Orally Bioavailable BET Bromodomain Inhibitor. J Med Chem60:3887-3901 (2017) [PubMed] Article |
---|
SMILES | COc1cc2c(cc1-c1c(C)noc1C)[nH]c1ncnc(-c3c(C)[nH]nc3C3CC3)c21 |(72.74,-39.4,;71.4,-38.64,;70.07,-39.41,;70.07,-40.95,;68.75,-41.71,;67.43,-40.95,;67.42,-39.42,;68.74,-38.65,;68.73,-37.1,;67.48,-36.2,;66.02,-36.69,;67.95,-34.74,;69.49,-34.73,;69.97,-36.19,;71.44,-36.66,;66.29,-41.97,;66.92,-43.37,;66.3,-44.75,;67.19,-45.99,;68.71,-45.82,;69.32,-44.43,;70.85,-44.26,;71.62,-42.93,;70.99,-41.52,;73.12,-43.24,;73.29,-44.78,;71.88,-45.41,;71.57,-46.91,;70.55,-48.06,;72.06,-48.38,;68.43,-43.21,)| |